Alan Fournier's portfolio and holdings - Jun 2024

As per corporate shareholdings filed for , people matching Alan Fournier publicly holds 40 stocks with a net worth of over US$ 653.8 M.

These are shares held by Alan Fournier as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.

ADD ALL SUPERSTAR ALERTS
Stock Name Holders Name Current Price US$ Quantity Held Holding Percent Change from Previous Qtr Holding Value US$ History
Perimeter Solutions SA Pennant Investors Lp 22.92 2,300,000 1.58% 0.00 52.7 M
ODP Corporation (The) Pennant Investors Lp 27.76 400,000 1.33% 0.14 11.1 M
EchoStar Corp - Ordinary Shares - Class A Pennant Investors Lp 72.38 2,153,209 0.79% 0.00 155.8 M
FibroGen Inc Pennant Investors Lp 10.38 768,400 0.76% -0.01 8.0 M
Antero Resources Corp Pennant Investors Lp 30.78 836,000 0.27% -0.10 25.7 M
Iris Energy Ltd Pennant Investors Lp 60.72 470,000 0.25% NEW 28.5 M
Valmont Industries, Inc. Pennant Investors Lp 404.86 40,000 0.20% NEW 16.2 M
BioXcel Therapeutics Inc Pennant Investors Lp 2.31 83,900 0.20% -0.03 193.8 K
Kalaris Therapeutics Inc. Pennant Investors Lp 4.63 215,700 0.19% 0.00 998.7 K
Core Scientific Inc - Ordinary Shares - New Pennant Investors Lp 19.00 500,000 0.18% NEW 9.5 M
Seres Therapeutics Inc Pennant Investors Lp 18.91 292,300 0.17% -0.02 5.5 M
Enanta Pharmaceuticals Inc Pennant Investors Lp 11.01 35,100 0.17% 0.00 386.5 K
Altimmune Inc Pennant Investors Lp 3.83 109,800 0.15% 0.00 420.5 K
Arcutis Biotherapeutics Inc Pennant Investors Lp 20.88 170,900 0.15% 0.00 3.6 M
Coherus Biosciences Inc Pennant Investors Lp 1.65 168,100 0.15% 0.00 277.4 K
Compass Therapeutics Inc Pennant Investors Lp 4.26 199,000 0.14% 0.00 847.7 K
Fate Therapeutics Inc Pennant Investors Lp 1.47 146,100 0.13% 0.00 214.8 K
Agenus Inc Pennant Investors Lp 3.88 469,600 0.11% 0.00 1.8 M
uniQure N.V. Pennant Investors Lp 58.00 48,500 0.10% 0.00 2.8 M
Nurix Therapeutics Inc Pennant Investors Lp 9.84 56,800 0.08% -0.01 558.9 K
Travere Therapeutics Inc Pennant Investors Lp 27.32 55,800 0.07% NEW 1.5 M
Macrogenics Inc Pennant Investors Lp 1.65 43,800 0.07% 0.00 72.3 K
Allogene Therapeutics Inc Pennant Investors Lp 1.23 128,400 0.06% 0.00 157.9 K
Erasca Inc Pennant Investors Lp 2.42 166,200 0.06% 0.00 402.2 K
Transdigm Group Incorporated Pennant Investors Lp 1265.88 32,371 0.06% -0.02 41.0 M
Zymeworks BC Inc Pennant Investors Lp 18.40 38,700 0.06% 0.00 712.1 K
Arcturus Therapeutics Holdings Inc Pennant Investors Lp 20.66 13,100 0.05% 0.00 270.6 K
Zentalis Pharmaceuticals Inc Pennant Investors Lp 1.49 32,400 0.05% 0.00 48.3 K
Replimune Group Inc Pennant Investors Lp 4.50 30,500 0.04% 0.00 137.3 K
89bio Inc Pennant Investors Lp 14.76 44,500 0.04% 0.00 656.8 K
Micron Technology Inc. Pennant Investors Lp 202.38 431,000 0.04% 0.01 87.2 M
Novavax, Inc. Pennant Investors Lp 8.10 60,300 0.04% 0.00 488.4 K
Vertiv Holdings Co - Ordinary Shares - Class A Pennant Investors Lp 174.00 115,000 0.03% NEW 20.0 M
Agios Pharmaceuticals Inc Pennant Investors Lp 42.33 15,100 0.03% 0.00 639.2 K
Arcus Biosciences Inc Pennant Investors Lp 16.47 23,700 0.03% 0.00 390.3 K
Relay Therapeutics Inc Pennant Investors Lp 6.49 42,400 0.03% -0.01 275.2 K
GE Vernova Inc. Pennant Investors Lp 600.00 60,000 0.02% NEW 36 M
Amazon.com Inc. Pennant Investors Lp 213.04 240,000 0.00% 0.00 51.1 M
Alphabet Inc - Ordinary Shares - Class A Pennant Investors Lp 253.30 183,000 0.00% 0.00 46.4 M
Microsoft Corporation Pennant Investors Lp 513.58 80,000 0.00% 0.00 41.1 M
View All The Superstar Shareholder Portfolios